CONSORT MEDICAL
LIVE

Serial Number

79267756

Owner

CONSORT MEDICAL PLC

Attorney

Max Vern

Filing Date

Jul 16, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CONSORT MEDICAL Trademark

Serial Number: 79267756 • Registration: 6071923

CONSORT MEDICAL is a trademark filed by CONSORT MEDICAL PLC on July 16, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 17 (Rubber Goods). The application is currently registered and active.

Owner Contact Info

CONSORT MEDICAL PLC (7 trademarks)

BREAKSPEAR PARK, BREAKSPEAR WAY
HEMEL HEMPSTEAD, HERTFORDSHIRE HP2 4UL , GB

Entity Type: 03

Trademark Details

Filing Date

July 16, 2019

Registration Date

June 9, 2020

Published for Opposition

March 24, 2020

Goods & Services

Provision of training, teaching and educational services in the nature of classes and tutorials all in the field of the delivery of drugs, pharmaceuticals and medicines; advisory, consultancy and information services relating to all the aforesaid

Custom manufacture of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; custom manufacture of components, parts and fittings for all the aforesaid products; management of product lifecycles for others, in the nature of custom manufacturing of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; provision of injection moulding services of plastic for others; custom manufacture of active pharmaceutical ingredients for others; custom manufacture of pharmaceuticals for others; advisory, consultancy and information services relating to all the aforesaid

Gaskets made of rubber or imitation rubber for use in systems for the delivery of drugs and medicines; non-metal gaskets for medical use

Pharmaceuticals and pharmaceutical preparations for the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders, drug addiction and opioid addiction; active pharmaceutical ingredients in the form of tablets, liquids, powders and skin patches and coatings for tablets and powders that facilitate the delivery of pharmaceuticals

Medical apparatus and instruments for the delivery of drugs and medicines; drug delivery devices; inhalers for medical use; metered dose inhalers for medical use; dry powder inhalers for medical use; inhaled drug delivery apparatus and instruments in the nature of a drug delivery system; hydrofluoralkanes (HFA) powered infusion and injection devices, systems, apparatus and instruments for use in drug and pharmaceutical delivery; hydrofluoralkanes (HFA) powered syringes, auto-injectors and injection devices for administrating pharmaceuticals and drugs; hydrofluoralkanes (HFA) powered infusion and injection devices, systems, apparatus and instruments for use in drug and pharmaceutical delivery incorporating audio, visual and/or tactile feedback mechanisms relating to drug and pharmaceutical delivery; hydrofluoralkanes (HFA) powered syringes, auto-injectors and injection devices for administrating pharmaceuticals and drugs incorporating audio, visual and tactile feedback mechanisms relating to drug and pharmaceutical delivery; syringes; syringe stoppers specially adapted for medical syringes; auto-injectors for pharmaceuticals; medical injectors for pharmaceuticals; disposable medical syringes and injectors; hypodermic syringes and injectors for pharmaceuticals; infusion and injection devices for administering pharmaceuticals and drugs; sterile apparatus for the administration of pharmaceuticals and drugs; cartridges specially adapted for medical syringes; nozzles specially adapted for medical syringes; drug delivery systems; oral and nasal medication aerosol dispensers; aerosol dispensers for medical purposes; parts and fittings for all the aforesaid; valves, pumps and actuators specially adapted for medical dispensers aerosols and powders; valves, pumps and actuators specially adapted for use in medical dispensers inhalers and drug dispensing and delivery systems; parts and fittings for all the aforesaid goods; elastomer parts for valves, pumps and actuators, specially adapted for medical apparatus and instruments for the delivery of drugs and medicines and for drug delivery systems

Product design and development of medical apparatus and instruments for others; product design and development of inhalers and drug delivery products for others; product design and development of pharmaceuticals, pharma and medical products and apparatus for others; prototyping services namely the development and manufacture of prototype products for use in the medical industry; metrology services; scientific laboratory services in the field of analytic testing; product quality testing services; quality control advisory services namely regulatory quality control advisory services in the field of pharmaceuticals, active pharmaceutical ingredients, medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; management of product lifecycles for others, in the nature of conducting and managing clinical trials and trials of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; advisory, consultancy and information services relating to all the aforesaid

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 9, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 18, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 30, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 9, 2020 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 13, 2020 NREP
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2020 TROA
REFUSAL PROCESSED BY IB
Nov 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 28, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 9, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 8, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 5, 2019 MAFR
ASSIGNED TO EXAMINER
Oct 1, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 19, 2019 REPR